CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Ensifentrine (formerly RPL554) 0.375 mg twice daily plus placebo, in addition to tiotropium - Phase 2 | VRNA Pipeline | CatalystAlert